(Q45410034)

14 December 2017

Hepatitis B virus genotype B is associated with better response to thymosin alpha1 therapy than genotype C. (English)

1 reference

14 December 2017

1 reference

2

1 reference

14 December 2017

R-N Chien

1

1 reference

PubMed ID

17109685

14 December 2017

C-T Yeh

series ordinal

3

1 reference

PubMed ID

17109685

14 December 2017

Y-F Liaw

series ordinal

4

1 reference

14 December 2017

1 December 2006

1 reference

Journal of Viral Hepatitis

14 December 2017

1 reference

14 December 2017

13

1 reference

14 December 2017

12

1 reference

14 December 2017

845-850

1 reference

Viral genetic variation: hepatitis B virus as a clinical example

14 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00761.X

Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00761.X

A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00761.X

Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00761.X

Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00761.X

Genotypes and clinical phenotypes of hepatitis B virus in patients with chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00761.X

Clinical significance of hepatitis B virus genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00761.X

Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00761.X

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00761.X

Hepatitis B viral genotypes and lamivudine resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00761.X

Virus and transaminase levels determine the emergence of drug resistance during long-term lamivudine therapy in chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00761.X

Determinants for sustained HBeAg response to lamivudine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00761.X

Sustained response after a 2-year course of lamivudine treatment of hepatitis B e antigen-negative chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00761.X

Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00761.X

Modulation of interleukin 2 receptor expression on normal human lymphocytes by thymic hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00761.X

Immunoregulatory effects of fraction 5 thymus peptides. I. Thymosin alpha 1 enhances while thymosin beta 4 suppresses the human autologous and allogeneic mixed lymphocyte reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00761.X

In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00761.X

Thymosin alpha1 treatment of chronic hepatitis B: results of a phase III multicentre, randomized, double-blind and placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00761.X

Mutations of polymerase, precore and core promoter gene in hepatitis B virus during 5-year lamivudine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00761.X

Hepatitis B virus of genotype B with or without recombination with genotype C over the precore region plus the core gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00761.X

Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00761.X

HBV core sequence: definition of genotype-specific variability and correlation with geographical origin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00761.X

Genetic basis of viral persistence: single amino acid change in the viral glycoprotein affects ability of lymphocytic choriomeningitis virus to persist in adult mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00761.X

Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00761.X

Clinical relevance of hepatitis B viral mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00761.X

Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00761.X

Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00761.X

Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00761.X

Hepatitis B genotypes and the response to interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00761.X

10.1111/J.1365-2893.2006.00761.X

21 January 2018

Identifiers

DOI

1 reference

14 December 2017

1 reference

PubMed ID

17109685